Palmar-plantar Erythrodysesthesia

• CLINICAL_TRIALS trial_result · 2026-02-02
  Clinical Trial Update: The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome [Phase 3]

  Phase 3 clinical trial assessing whether mecobalamin prevents capecitabine-induced hand-foot syndrome; the study is currently active but not…

• CLINICAL_TRIALS trial_result · 2026-01-14
  Clinical Trial Update: Efficacy and Safety of Moisturising Cream With or Without Vitamin E and Urea Cream in Palmar-plantar Erythrodysesthesia [NA]

  A completed clinical trial assessed the efficacy and safety of a moisturising cream used alone or with Vitamin E and Urea for Palmar-Plantar…

• CLINICAL_TRIALS trial_result · 2019-10-08
  Clinical Trial Update: Study of 0.1% Uracil Topical Cream (UTC) for the Prevention of Hand-Foot Syndrome [Phase 1, Phase 2]

  Phase 1/2 trial evaluating 0.1% Uracil Topical Cream for prevention of hand-foot syndrome in breast cancer patients; study completed.

• CLINICAL_TRIALS trial_result · 2019-05-15
  Clinical Trial Update: F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Liposome for Metastatic Breast Cancer [Phase 3]

  Phase 3 trial evaluating F511 Cream to prevent hand-foot syndrome in patients with metastatic breast cancer receiving liposomal doxorubicin.

• CLINICAL_TRIALS trial_result · 2014-02-25
  Clinical Trial Update: Study of Pyridoxine for Hand-Foot Syndrome [Phase 3]

  Phase 3 trial evaluating pyridoxine (vitamin B6) for hand-foot syndrome has completed and results were posted in 2014.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2012-10-30
  Clinical Trial Update: Treatment of Palmar Plantar Erythrodysesthesia (PPE) With Topical Sildenafil [Phase 1]

  A Phase 1 study evaluating topical sildenafil for palmar-plantar erythrodysesthesia (hand-foot syndrome) has been completed.